CAMP4 Therapeutics Corporation (CAMP) vs Profound Medical Corp. (PROF)
A side-by-side comparison of CAMP4 Therapeutics Corporation and Profound Medical Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.86HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
PROF
Profound Medical Corp.
$6.15HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
Total return — CAMP vs PROF
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)PROF -21.6% (-11.4%/yr)PROF compounded faster over this window
CAMP PROF
CAMP vs PROF: by the numbers
- •CAMP is the larger company ($242M vs $223M market cap).
- •Both run net losses; PROF's is the smaller (-171.72% vs -2543.74% net margin).
- •PROF grew revenue faster over the past five years (16.55% vs -57.68% CAGR).
Metrics side by side
Valuation
| Metric | CAMP | PROF |
|---|---|---|
| P/S ratio | 57.45 | 11.75 |
| P/B ratio | N/A | 4.49 |
Profitability
| Metric | CAMP | PROF |
|---|---|---|
| Gross margin | 53.14% | 71.79% |
| Operating margin | -1488.31% | -256.27% |
| Net margin | -2543.74% | -171.72% |
| ROE | N/A | -65.59% |
| ROIC | -69.76% | -61.03% |
Growth (annualized)
| Metric | CAMP | PROF |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | 16.55% |
| Total return CAGR (5Y) | N/A | -15.23% |
Frequently asked
- Which has grown faster, CAMP or PROF?
- Over the past five years, PROF grew revenue faster — CAMP at a -57.68% CAGR versus PROF at 16.55%.
Go deeper
Dig into the metrics
CAMP4 Therapeutics ROEProfound Medical ROECAMP4 Therapeutics operating marginProfound Medical operating marginCAMP4 Therapeutics revenue growthProfound Medical revenue growthCAMP4 Therapeutics free cash flowProfound Medical free cash flow
CAMP4 Therapeutics & Profound Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.